Brain metastases free survival differs between breast cancer subtypesAnna S. Berghoff, Rupert Bartsch, Zsuzsanna Bagó-Horváth et al.|British Journal of Cancer|2012Cited by 94
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastasesRupert Bartsch, G. Steger, Anna S. Berghoff et al.|British Journal of Cancer|2011Cited by 77
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancerRupert Bartsch, Guenther G. Steger, Zsuzsanna Bagó-Horváth et al.|European Journal of Cancer|2012Cited by 52
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancerRupert Bartsch, Guenther G. Steger, Catharina De Vries et al.|BMC Cancer|2009Cited by 22
Brain metastasis-free survival in patients with HER2-positive metastatic breast cancer.Anna S. Berghoff, Rupert Bartsch, Zsuzsanna Bagó-Horváth et al.|Journal of Clinical Oncology|2011Cited by 3